A Study of MEDI-575 in Subjects with Recurrent Glioblastoma Multiforme

Study identifier:CD-ON-MEDI-575-1042

ClinicalTrials.gov identifier:NCT01268566

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase 2 Study of MEDI-575 in Adult Subjects with Recurrent Glioblastoma Multiforme

Medical condition

Glioblastoma Multiforme

Phase

Phase 2

Healthy volunteers

No

Study drug

MEDI-575

Sex

All

Actual Enrollment

62

Study type

Interventional

Age

18 Years - 95 Years

Date

Study Start Date: 01 Jan 2011
Primary Completion Date: 01 Nov 2012
Study Completion Date: 01 Nov 2012

Study design

Allocation: N/A
Endpoint Classification: Efficacy
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Feb 2017 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

-

Inclusion and exclusion criteria